Mild nausea in the first 6-8 hours post-injection (12-15% of reviews) Transient nausea, typically resolving within 8 hours
However, its important to assess how much of this perceived benefit is supported by evidence and what outcomes practitioners and patients can realistically expect
Yes, AOD 9604 is generally well-tolerated by patients with thyroid disorders, perimenopause, or adrenal imbalances
We included MIC, which helps suppress appetite, energy and help you focus on your workout and meet your goals
By educating patients about benefits, honestly disclosing risks, screening for contraindications, and documenting everything clearly, you build trust, ensure safety, and create a defensible record if questions ever arise